| 1 |
2024 |
Elodie A.Y. Masson, Jeanne Serrano, Elise Leger-Charnay, Niyazi Acar. Cholesterol and oxysterols in retinal neuron-glia interactions: relevance for glaucoma, Frontiers in Ophthalmology. 2024; 3: 1303649.
https://doi.org/10.3389/fopht.2023.1303649 |
| 2 |
2024 |
Polina Petkova-Kirova, Anastasia Kolchina, Stephan Baas, Gudrun Wagenpfeil, Marcus Michael Unger, Julia Maria Schulze-Hentrich, Rita Bernhardt. SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson’s disease, Frontiers in Pharmacology. 2024; 15: 1477009.
https://doi.org/10.3389/fphar.2024.1477009 |
| 3 |
2022 |
Nicole El-Darzi, Natalia Mast, David A. Buchner, Aicha Saadane, Brian Dailey, Georgios Trichonas, Irina A. Pikuleva. Low-Dose Anti-HIV Drug Efavirenz Mitigates Retinal Vascular Lesions in a Mouse Model of Alzheimer’s Disease, Frontiers in Pharmacology. 2022; 13: 902254.
https://doi.org/10.3389/fphar.2022.902254 |
| 4 |
2023 |
Nicole El-Darzi, Natalia Mast, Yong Li, Brian Dailey, Min Kang, Douglas J. Rhee, Irina A. Pikuleva. The normalizing effects of the CYP46A1 activator efavirenz on retinal sterol levels and risk factors for glaucoma in Apoj−/− mice, Cellular and Molecular Life Sciences. 2023; 80: 194.
https://doi.org/10.1007/s00018-023-04848-y |
